BMJ Neurology Open is an online, peer-reviewed, open access journal, dedicated to publishing medical research in all areas of clinical neurology and neuroscience.
It will have a particular focus on addressing common neurological diseases and their treatment and implementation studies which look at how neurological advances can be brought to the patients who need them.
BMJ Neurology Open is co-owned by BMJ and the Australia and New Zealand Association of Neurologists (ANZAN). The title is a sister journal to the Journal of Neurology, Neurosurgery, and Psychiatry.
The journal will, says BMJ, maintain a rigorous and transparent peer review process and will adhere to the highest ethical standards for research as part of BMJ’s vision for a healthier world.
And in common with BMJ’s other titles, BMJ Neurology Open will operate a fast submission and review process with continuous publication online, to ensure that the most up-to-date research is available worldwide.
The new title is edited by Professor Richard Gerraty, a stroke neurologist based in Australia. He was the founding director of the Acute Stroke Unit at St Vincent’s Hospital, Melbourne, and has also had appointments in clinical stroke and stroke research at the Royal Melbourne and the Alfred hospital.
Commenting on his new appointment, Professor Gerraty, said: “It is my ambition that this journal will publish original research, reviews, protocols, and viewpoints, that will be insightful and significant to the field of neurology. By doing this, I know that this new, open access journal will be recognised as a trusted resource and held in high esteem by all health professionals working in the field of neurology.”
Professor Matthew Kiernan, President of the Australian and New Zealand Association of Neurologists said: “As someone who has extensive experience in research excellence and academic leadership nationally and internationally, I am confident that this new, open access journal will provide the most relevant and innovative information to all health professionals who work within any field related to clinical neurology and neuroscience. It is my hope that by providing open access to reliable research and the latest evidence-based practice, we will improve patient outcomes globally for all.”